Literature DB >> 9607194

Gene transfer of RANTES elicits autoimmune renal injury in MRL-Fas(1pr) mice.

K J Moore1, T Wada, S D Barbee, V R Kelley.   

Abstract

We report that the beta-chemokine RANTES, a chemoattractant for macrophages and T cells, is up-regulated in the MRL-Fas(1pr) kidney prior to injury, but not normal kidneys (MRL-++, C3H-++) and increases with progressive injury. Furthermore, we establish an association between RANTES expression in the kidney and renal damage using a gene transfer approach. Tubular epithelial cells genetically modified to secrete RANTES infused under the renal capsule incites interstitial nephritis in MRL-Fas(1pr), but not MRL-++ or C3H-++ mice. RANTES recruits predominantly macrophages (M phi) and CD4+ and CD8+ T cells. In contrast, gene transfer of CSF-1, another molecule up-regulated simultaneously with RANTES in MRL-Fas(1pr) kidneys, promotes the influx of M phi, CD4+ T cells and the unique double-negative (DN) T cells (CD4-, CD8-), which are prominent in diseased MRL-Fas(1pr) kidneys. Thus, RANTES and CSF-1 recruit distinct T cell populations into the MRL-Fas(1pr) kidney. In addition, delivery of RANTES and CSF-1 into the kidney of MRL-Fas(1pr) mice causes an additive increase in pathology. We suggest that the complementary recruitment of T cell populations by RANTES (CD4, CD8) and CSF-1 (CD4, DN) promotes autoimmune nephritis in MRL-Fas(1pr) mice.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9607194     DOI: 10.1046/j.1523-1755.1998.00911.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  19 in total

Review 1.  Role of TWEAK in lupus nephritis: a bench-to-bedside review.

Authors:  Jennifer S Michaelson; Nicolas Wisniacki; Linda C Burkly; Chaim Putterman
Journal:  J Autoimmun       Date:  2012-06-22       Impact factor: 7.094

Review 2.  T cells and B cells in lupus nephritis.

Authors:  Mary H Foster
Journal:  Semin Nephrol       Date:  2007-01       Impact factor: 5.299

3.  N-Acetyl-Seryl-Aspartyl-Lysyl-Proline: mechanisms of renal protection in mouse model of systemic lupus erythematosus.

Authors:  Tang-Dong Liao; Pablo Nakagawa; Branislava Janic; Martin D'Ambrosio; Morel E Worou; Edward L Peterson; Nour-Eddine Rhaleb; Xiao-Ping Yang; Oscar A Carretero
Journal:  Am J Physiol Renal Physiol       Date:  2015-03-04

Review 4.  Tumor necrosis factor-like weak inducer of apoptosis and its potential roles in lupus nephritis.

Authors:  Zhi-Chun Liu; Qiao-Ling Zhou
Journal:  Inflamm Res       Date:  2012-04       Impact factor: 4.575

5.  The Friend leukaemia virus integration 1 (Fli-1) transcription factor affects lupus nephritis development by regulating inflammatory cell infiltration into the kidney.

Authors:  S Sato; X K Zhang
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

6.  The Fli-1 transcription factor regulates the expression of CCL5/RANTES.

Authors:  Mara L Lennard Richard; Shuzo Sato; Eiji Suzuki; Sarah Williams; Tamara K Nowling; Xian K Zhang
Journal:  J Immunol       Date:  2014-08-06       Impact factor: 5.422

7.  Differential cytokine production and bystander activation of autoreactive B cells in response to CpG-A and CpG-B oligonucleotides.

Authors:  Ana M Avalos; Eicke Latz; Betty Mousseau; Sean R Christensen; Mark J Shlomchik; Frances Lund; Ann Marshak-Rothstein
Journal:  J Immunol       Date:  2009-10-28       Impact factor: 5.422

8.  Activation profile of Toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus.

Authors:  C K Wong; P T Y Wong; L S Tam; E K Li; D P Chen; C W K Lam
Journal:  Clin Exp Immunol       Date:  2009-10-16       Impact factor: 4.330

9.  CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease.

Authors:  Julia Menke; Geraldine C Zeller; Eriya Kikawada; Terry K Means; Xiao R Huang; Han Y Lan; Bao Lu; Joshua Farber; Andrew D Luster; Vicki R Kelley
Journal:  J Am Soc Nephrol       Date:  2008-03-12       Impact factor: 10.121

10.  Inhibition of the TWEAK/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritis.

Authors:  Yumin Xia; Sean R Campbell; Anna Broder; Leal Herlitz; Maria Abadi; Ping Wu; Jennifer S Michaelson; Linda C Burkly; Chaim Putterman
Journal:  Clin Immunol       Date:  2012-08-20       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.